30
nanotimes
Companies Facts
In connection with the Tender Offer, Headwaters is also soliciting consents (“Consents”) from the holders of the Notes for certain proposed amendments to the indenture governing the Notes (the “Consent Solici- tation”). Holders that validly tender their Notes will be deemed to have delivered their Consent to the proposed amendments. Holders may not tender their Notes without delivering their Consents to the propo- sed amendments and may not deliver their Consents without tendering their Notes. The primary purpose of the Consent Solicitation and the proposed amend- ments is to eliminate substantially all of the restrictive covenants and certain events of default.
On March 08, 2011, Headwaters announced the pricing of its offering of $400.0 million aggregate principal amount of 7-5/8% Senior Secured Notes due 2019 (the “Notes”). The Notes will be senior secured obligations of Headwaters and will be gua- ranteed by certain of Headwaters’ existing and future domestic subsidiaries. The offering is expected to close on March 11, 2011, subject to certain closing conditions. Headwaters expects net proceeds from the offering to be approximately $393.3 million (after deducting the initial purchasers’ commissions and estimated transaction fees and expenses).
Headwaters intends to use the net proceeds to fund the previously announced tender offer for any and all of its $328.3 million aggregate principal amount of 11-3/8% Senior Secured Notes due 2014 outstan- ding (the “11-3/8% Notes”) and to pay related tender premiums and transaction fees and expenses. Furthermore, the Company announced that coal ash produced at the Virginia City Hybrid Energy Center will be managed by a subsidiary of Headwaters In- corporated. Headwaters is America‘s largest manager
I
11-02/03 :: February / March 2011
BM’s (NYSE: IBM) announcement of the first biodegradable nanoparticles that can seek
out and destroy drug-resistant bacteria caps off a century of healthcare and life sciences innova- tion from IBM. Earlier this week, scientists from IBM Research announced ground breaking early research discovering new types of nanoparti- cles that are physically attracted like magnets to MRSA cells, ignoring healthy cells completely and targeting and killing the bacteria by poking holes in its walls. This discovery could greatly improve the effectiveness of medication. This innovation is just one example of IBM’s ability to use principles and technologies from computing, physics, mate- rials science and chemistry to advance the science of medicine.
http://www.ibm.com http://www.youtube.com/ibmhealthcare
and marketer of coal combustion products – under a long-term contract recently signed with the plant owner, Dominion Virginia Power. The 585-mega- watt power plant is currently under construction in
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95